Lupin Pharmaceuticals Inc. gets FDA go-ahead
Daily Record, The (Baltimore), Jul 19, 2007
Lupin Pharmaceuticals Inc., an Indian company whose sales and marketing headquarters is in Baltimore, said it received permission from the Food and Drug Administration to market Amlodipine Beylate tablets, a generic drug used to treat high blood pressure. Commercial shipments of tablets in 2.5 milligram, 5 mg and 10 mg doses will commence shortly, the company said.
Amlodipine Beylate tablets are a counterpart to Norvasc, manufactured by Pfizer Inc., which accrued sales of approximately $2.7 billion for the 12 months ended December 2006.
Copyright 2007 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
Most Popular Business Publications
Content provided in partnership with
Presented by American Express